Induction chemotherapy for larynx preservation: Patient selection or therapeutic effect?

Journal of Clinical Oncology

Volumn 24, Issue 4, 2006, Pages 540-543

  Pfister, David G ^a   Ridge, John A ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDITORIAL; HEAD AND NECK CANCER; HUMAN; LARYNGECTOMY; LARYNX CANCER; MEDICAL PRACTICE; MULTIPLE CYCLE TREATMENT; ORGAN PRESERVATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; TREATMENT PLANNING; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; LARYNX TUMOR; METHODOLOGY; MORTALITY; NOTE; PATHOLOGY; PATIENT SELECTION; REMISSION; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; NEOADJUVANT THERAPY; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SURVIVAL RATE;

EID: 33644835457     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.1954     Document Type: Editorial

References (18)

1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685-1690, 1991
2. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899, 1996
3. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003
4. Brockstein B, Haraf DJ, Rademaker AW, et al: Patterns of failure, prognostic factors, and survival in locoregionally head and neck cancer treated with concomitant chemoradiotherapy: A 9 year, 337 patient, multi-institutional experience. Ann Oncol 15:1179-1186, 2004
5. Posner MR, Haddad RI, Wirth L, et al: Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: Evolution of the sequential treatment approach. Semin Oncol 31:778-785, 2004
6. Urba S, Wolf G, Eisbruch A, et al: Single-cycle induction chemotherapy select patients with advanced laryngeal cancer for combined chemoradiation: A new treatment paradigm. J Clin Oncol 24:593-598, 2006
7. Spaulding MB, Fischer SG, Wolf GT: Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. J Clin Oncol 12:1592-1599, 1994
8. Dropkin MJ: Body image and quality of life after head and neck cancer surgery. Cancer Pract 7:309-313, 1999
9. McNeil BJ, Weichselbaum R, Pauker SG: Speech and survival: Tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 305:982-987, 1981
10. List MA, Stracks J, Colangelo L, et al: How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol 18:877-884, 2000
11. Bernier J, Domenge C, Ozsahin M, et al: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945-1952, 2004
12. Cooper JS, Pajak TF, Forastiere AA, et al: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944, 2004
13. Schrag D, Garewal HS, Burstein HJ, et al: American Society of Clinical Oncology technology assessment: Chemotherapy sensitivity and resistance assays. J Clin Oncol 22:3631-3638, 2004
14. Hanna E, Alexiou M, Morgan J, et al: Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: Efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 130:861-867, 2004
15. Paccagnella A, Orlando A, Marchiori, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancer: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86:265-272, 1994
16. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program. Cancer 60:301-311, 1987
17. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998
18. Al-Sarraf M, LeBlanc M, Girl PG, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16:1310-1317, 1998